Indian News
-
Aug 06 2013
Pharma industry challenges new drug pricing policyMove expected to delay introduction of low priced medicines in the market
Taking cue from Cipla and Alembic, many in the pharmaceutical…
Read more -
Indian generic cos struggle to crack 2nd largest pharma marketExcept a few Indian players such as Lupin, none of the Indian drug makers are able to establish their presence in the $90-bn pharma market
The world’s second largest pharmaceutical pharmaceuticals market -Japan is yet…
Read more -
New drug policy: Benefits yet to reach consumers
New drug policy: Benefits yet to reach consumers P. T.…
Read more -
Diabetes drug Pioglitazone is back, with a ‘bold red letter’ warning
MUMBAI, AUGUST 1: Diabetes drug pioglitazone and all its combinations…
Read more -
Aanjaneya Lifecare Bounces Back, Acquires two firms in Hong Kong, UK Fair Success Hong Kong and Dr. Datsons Labs
Aanjaneya Lifecare Limited, India’s fastest growing Pharmaceutical Group having a…
Read more -
Prakash Guha Led Zuventus Healthcare Wins at 4th Annual India Leadership Conclave 2013
Prakash Guha Led Zuventus Healthcare Wins at 4th Annual India…
Read more -
‘India’s pharma sector is of proven global quality’
With recent reports questioning the quality of drugs made in…
Read more -
Ranbaxy issue a wake up call for Indian pharma industry: Biocon chief Kiran Mazumdar
The $500 million fine on Ranbaxy by US authorities after…
Read more -
Govt to finalise FDI policy in pharma before FIPB meet
NEW DELHI: The government is likely to finaliseFDI policy with…
Read more -
Congress Questions India Pharma Patent Practices
Last week a Congressional subcommittee held a hearing on India’s’…
Read more